Medical Specialty >> Pharmacy
Fatal Opioid ODs Rise as Temperatures Fall
4:00 PM CDT.
Read article
- Sudden Death Can Occur Even in Well-Controlled Epilepsy
- Statins May Lower Risk of Stroke After Cancer Radiotherapy
- Sprouts Supermarkets Recalls Frozen Spinach Due to Listeria Fears
- More Women Using Pot During Pregnancy, Despite Potential Harms to Baby
JOURNAL UPDATE
Cardiovascular AEs Common With Carfilzomib in Multiple Myeloma
12:00 PM CDT. Patients with relapsed multiple myeloma experiencing CVAEs had inferior survival- Statins May Be Beneficial After Radiation to Thorax, Head, Neck
- Patterns of Inpatient Opioid Use Linked to Long-Term Use
- Pediatric T1DM Medication Adherence Drops on Weekends, Holidays
MONTHLY JOURNAL SUMMARY
May 2019 Briefing - Pharmacy
June 03, 2019. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
Ted Lain, MD.
Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
Bevacizumab for breast cancer: FDA grants a stay of execution
Dr. Alberto De la Guerra.
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
MEDICAL FOCUS
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By namabcAs I understand, this is a great step of development that we can use to save many people from horrible diseases. and i also hope Dr.Lain and your partners…
